Mild Cognitive Impairment Clinical Trial
Official title:
Virtual Exercise Intervention for Older Adults With MCI
Verified date | March 2023 |
Source | Oregon Research Institute |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
This project is designed to develop and evaluate an Internet-based exercise intervention (tai ji quan Moving to Improve Brain Health) using real-time videoconferencing for older adults with mild cognitive impairment (MCI).
Status | Completed |
Enrollment | 69 |
Est. completion date | October 30, 2022 |
Est. primary completion date | August 30, 2022 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 65 Years to 95 Years |
Eligibility | Inclusion criteria: - Self-report a change or decline in memory (corroborated by an informant) - Record a score of =0.5 on the Clinical Dementia Rating (CDR) scale (with information derived from both the participant and an informant) - Show no major impairment in cognitive function as indexed by a score of =24 on the Mini Mental State Evaluation (MMSE). Exclusion criteria: - Have participated in a rigorous and structured physical activity or exercise program (including Tai Ji Quan) in the past 6 months, - Show major signs of depression as indicated by a score of =5 on the Geriatric Depression Scale - Have major medical or physical conditions that preclude exercise, as determined by their healthcare practitioner - Being unable to follow the consent process or sign the study consent form. |
Country | Name | City | State |
---|---|---|---|
United States | Oregon Research Institute | Eugene | Oregon |
Lead Sponsor | Collaborator |
---|---|
Oregon Research Institute |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | (a) Total number of intervention sessions taught by instructors over the course of study (recorded by a class check sheet) and (b) total number of classes attended by participants over the course of intervention as recorded by class attendance sheet | assess the extent to which interventionists successfully implement the prespecified exercise training protocol. | 16 weeks | |
Primary | number of dropouts from the intervention and study as assessed by a study recording sheet | assess intervention dropout rate and retention rate | 16 weeks | |
Primary | Number of participants expressing intervention program satisfaction as assessed by a self-report survey | assess the program acceptability among tai ji quan participants | 16 weeks | |
Primary | Change in global cognitive function assessed by Montreal Cognitive Assessment | assess change from baseline cognitive function at 16 weeks | baseline, 16 weeks | |
Primary | Change in attention and working memory as assessed by Digit Span - forward and backward | assess change from baseline in attention and working memory at 16 weeks | baseline, 16 weeks | |
Primary | Change in dual-task cost as assessed by Timed Up and Go with a cognitive task | assess change from baseline in the ability to stand up from a chair, walk, and sit down while performing an arithmetic task at 16 weeks | baseline, 16 weeks | |
Primary | Change in executive function as assessed by Trail Making B | assess change from baseline executive function at 16 weeks | baseline, 16 weeks | |
Primary | Change in executive function as assessed by Category Fluency for Animals | assess change from baseline executive function at 16 weeks | baseline, 16 weeks | |
Primary | Change in cognitive functioning assessed by Everyday Cognition | assess change from baseline cognitive functioning at 16 weeks | baseline, 16 weeks | |
Primary | Change in physical performance as measured by Timed Up and Go test | assess change from baseline in the ability to stand up from a chair, walk, and sit down at 16 weeks | baseline, 16 weeks | |
Primary | change in leg strength as assessed by 30-second chair stand test | assess change from baseline in leg strength at 16 weeks | baseline, 16 weeks | |
Primary | Change in balance using a 4-stage balance test | assess change from baseline in balance at 16 weeks | baseline, 16 weeks | |
Secondary | Change in depression as assessed by Geriatric Depression scale | assess change from baseline in the level of depression at 16 weeks | baseline, 16 weeks | |
Secondary | Change in physical activity as assessed by International Physical Activity Questionnaire | assess change from baseline in physical activity at 16 weeks | baseline, 16 weeks | |
Secondary | Change in quality of life as assessed by EuroQol (EQ-5D-3L) | assess change from baseline in quality of life at 16 weeks | baseline, 16 weeks |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT04513106 -
Promoting Advance Care Planning for Persons With Early-stage Dementia in the Community: a Feasibility Trial
|
N/A | |
Recruiting |
NCT06011681 -
The Rapid Diagnosis of MCI and Depression in Patients Ages 60 and Over
|
||
Recruiting |
NCT04522739 -
Spironolactone Safety in African Americans With Mild Cognitive Impairment and Early Alzheimer's Disease
|
Phase 4 | |
Active, not recruiting |
NCT03167840 -
Falls Prevention Through Physical And Cognitive Training in Mild Cognitive Impairment
|
N/A | |
Active, not recruiting |
NCT03676881 -
Longitudinal Validation of a Computerized Cognitive Battery (Cognigram) in the Diagnosis of Mild Cognitive Impairment and Alzheimer's Disease
|
||
Not yet recruiting |
NCT05041790 -
A Clinical Trial to Evaluate the Efficacy and Safety of Choline Alfoscerate Compared to Placebo in Patients With Degenerative Mild Cognitive Impairment
|
Phase 4 | |
Recruiting |
NCT04121156 -
High Definition Transcranial Direct Current Stimulation (HD-tDCS) in Patients With Mild Cognitive Impairment
|
N/A | |
Recruiting |
NCT03605381 -
MORbidity PRevalence Estimate In StrokE
|
||
Completed |
NCT02774083 -
Cognitive Training Using Feuerstein Instrumental Enrichment
|
N/A | |
Completed |
NCT01315639 -
New Biomarker for Alzheimer's Disease Diagnostic
|
N/A | |
Enrolling by invitation |
NCT06023446 -
Can (Optical Coherence Tomography) Pictures of the Retina Detect Alzheimer's Disease at Its Earliest Stages?
|
||
Completed |
NCT04567745 -
Automated Retinal Image Analysis System (EyeQuant) for Computation of Vascular Biomarkers
|
Phase 1 | |
Recruiting |
NCT05579236 -
Cortical Disarray Measurement in Mild Cognitive Impairment and Alzheimer's Disease
|
||
Completed |
NCT03583879 -
Using Gait Robotics to Improve Symptoms of Parkinson's Disease
|
N/A | |
Terminated |
NCT02503501 -
Intranasal Glulisine in Amnestic Mild Cognitive Impairment and Probable Mild Alzheimer's Disease
|
Phase 2 | |
Not yet recruiting |
NCT03740178 -
Multiple Dose Trial of MK-4334 in Participants With Alzheimer's Clinical Syndrome (MK-4334-005)
|
Phase 1 | |
Active, not recruiting |
NCT05204940 -
Longitudinal Observational Biomarker Study
|
||
Recruiting |
NCT02663531 -
Retinal Neuro-vascular Coupling in Patients With Neurodegenerative Disease
|
N/A | |
Recruiting |
NCT06150352 -
Sleep Apnea, Neurocognitive Decline and Brain Imaging in Patients With Subjective or Mild Cognitive Impairment
|
||
Recruiting |
NCT03507192 -
Effects of Muscle Relaxation on Cognitive Function in Patients With Mild Cognitive Impairment and Early Stage Dementia.
|
N/A |